FDA Adverse Event Malfunction Summary report: N

COATED VICRYL PLUS ANTIBACTERIAL (POLYGLACTIN 910)

MDR report key: 3003828 · Received March 14, 2013

Report

Report Number
2210968-2013-02436
Event Type
Malfunction
Date Received
March 14, 2013
Date of Event
February 7, 2013
Report Date
February 18, 2013
Manufacturer
ETHICON, INC.
Product Code
GAM
PMA / PMN Number
K032420
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: REPRESENTATIVE SAMPLES FROM THE SAME LOT NUMBER AS THE ACTUAL DEVICE WERE RETURNED FOR EVALUATION. NEEDLES AND SUTURES OF THE UNOPENED PACKETS WERE EXAMINED UNDER 10-X MAGNIFICATION FOR ATTRIBUTES DEFECTS. NO NEEDLE OR SUTURE DEFECTS WERE NOTED.

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: THE PRODUCT UPON WHICH THIS MEDWATCH IS BASED IS ANTICIPATED. ONCE THE PRODUCT IS RECEIVED, ANY FURTHER INFORMATION DERIVED FROM THE EVALUATION WILL BE SUBMITTED IN A SUPPLEMENTAL 3500A FORM. ADDITIONAL INFORMATION: THE ACTUAL DEVICE BATCH NUMBER ASSOCIATED WITH THIS EVENT IS NOT KNOWN. THE INTERNATIONAL AFFILIATE REPORTS THE FOLLOWING POSSIBLE BATCH NUMBERS: BATCH DK2479, MFG DATE: NI, EXP DATE: NI. BATCH EL2588, MFG DATE: NI, EXP DATE: NI. BATCH EC2829, MFG DATE: NI, EXP DATE: NI. BATCH EM2641, MFG DATE: NI, EXP DATE: NI. BATCH EE2147, MFG DATE: NI, EXP DATE: NI. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS FOR THE POSSIBLE BATCH NUMBERS WAS CONDUCTED AND THE BATCHES MET ALL FINISHED GOODS RELEASE CRITERIA.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT A HYSTERECTOMY ON (B)(6) 2013 AND SUTURE WAS USED. WHILE SUTURING THE FASCIA, THE NEEDLE BROKE, THE NEEDLE FRAGMENT WAS RETRIEVED. THERE WERE NO ADVERSE PATIENT CONSEQUENCES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
107345 COATED VICRYL PLUS ANTIBACTERIAL (POLYGLACTIN 910) SUTURE, ABSORBABLE GAM ETHICON, INC. NA NI

Patients

Seq Age Sex Outcome Treatment
1